Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Abbott Laboratories (Pakistan)

1948 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
ABOT STOCK SYMBOL
$4.59 SHARE PRICE (As of Friday Closing)
Description

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing and marketing of research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products. The company's operating segments are Pharmaceutical, Nutritional, and Others. The Pharmaceutical segment is engaged in the manufacturing, importing and marketing of research-based pharmaceutical products registered with the Drug Regulatory Authority of Pakistan. The Nutritional segment is engaged in the importing and marketing of pediatric nutritional products and medical nutritional products. The Others segment represents the manufacturing, importing and marketing of diagnostic equipment, diabetes care, molecular devices, their testing kits and general healthcare products.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Pharmaceuticals
Stock Exchange
KAR
Primary Office
  • House No.222/5
  • Khadim Hussain Road, near Lal Kurti, Rawalpindi Cantt.
  • Rawalpindi
  • Pakistan

+92 (051) 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abbott Laboratories (Pakistan)’s full profile, request a free trial.

Abbott Laboratories (Pakistan) Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.54 - $6.41 $449M $4.55 $0.31 14.3K

Abbott Laboratories (Pakistan) Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 442,469 544,014 816,073 510,734
Revenue 250,408 244,282 220,252 203,338
EBITDA 50,024 60,481 57,714 48,434
Net Income 30,088 39,376 37,875 34,450
Total Assets 151,703 171,972 166,571 155,155
Total Debt 1,326
Public Fundamental Data provided by Morningstar, Inc. disclaimer